297pcomparison of the Efficacy of 9-weeks versus 52-weeks of Adjuvant Trastuzumab Treatment in Her-2 Positive Early-stage Breast Cancer with Axillary Lymph Node Metastases.

Abstract

Semantic Scholar extracted view of "297pcomparison of the Efficacy of 9-weeks versus 52-weeks of Adjuvant Trastuzumab Treatment in Her-2 Positive Early-stage Breast Cancer with Axillary Lymph Node Metastases." by Mehmet An Şendur et al.

Topics

    0 Figures and Tables

      Download Full PDF Version (Non-Commercial Use)